Physician profile
Amit Bansal
NPI 1649582271
$2,432.44
in general payments reported to CMS, 2019-2025
21 companies · $39.57 in 2025
The $39.57 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $341 · 2021: $602 · 2022: $820 · 2023: $519 · 2024: $111 · 2025: $39.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $669.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $309.67 | 2021-2023 | Repatha |
| Merck Sharp & Dohme LLC | $296.41 | 2021-2023 | Verquvo |
| Pfizer INC. | $284.53 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $277.54 | 2020-2022 | |
| Abbott Laboratories | $189.42 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Heartmate Touch |
| Chiesi USA, INC. | $168.90 | 2021-2023 | Kengreal |
| Novartis Pharmaceuticals Corporation | $154.62 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.61 | 2020-2023 | Jardiance |
| Amarin Pharma, INC. | $94.08 | 2020-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $82.81 | 2020-2021 | |
| Abiomed | $74.81 | 2022 | |
| Boston Scientific Corporation | $62.24 | 2020-2022 | |
| Alnylam Pharmaceuticals INC. | $61.10 | 2021-2023 | Onpattro |
| Impulse Dynamics (USA) INC. | $51.20 | 2023 | Optimizer |
| Akcea Therapeutics, INC. | $47.01 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $36.41 | 2022 | |
| Inari Medical, INC. | $34.77 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $25.36 | 2022 | |
| Haemonetics Corporation | $24.06 | 2022 | |
| Astellas Pharma US INC | $21.51 | 2025 | Xtandi |
| Novo Nordisk INC | $21.38 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Bansal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.